N/A N=12 Randomized Single-blind Treatment

Cerebral Palsy: Short-burst Interval Training

Cerebral Palsy Spastic Diplegia

Bottom Line

View on ClinicalTrials.gov: NCT03373890 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2019

Primary outcome: Primary: Change in Walking Performance High Versus Low Frequency SBLTT Groups — 1872; 1551 strides per day — p=.39

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Short Burst Interval Locomotor Treadmill Training (SBLTT) (Behavioral)
Age: Pediatric · 5+ yrs
Sex: All
Sponsor: Seattle Children's Hospital
Primary completion: Jul 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Walking Performance High Versus Low Frequency SBLTT Groups	1872; 1551	.39
PRIMARY Change in Community Walking Performance Intensity High Versus Low Frequency SBLTT Groups	866; 731	.39
PRIMARY Change in Walking Capacity High Versus Low Frequency SBLTT Groups	.21; -.08	.03 sig
PRIMARY Change in Walking Endurance- High Versus Low Frequency SBLTT Groups	13.8; 8.8	.39
SECONDARY Change in Muscle Performance -Power High Versus Low Frequency SBLTT Groups	1.2; 1.9	.06
SECONDARY Change in Muscle Performance - Strength High Versus Low Frequency SBLTT Groups	.13; .14	.99
SECONDARY Change in Muscle Architecture-High Versus Low Frequency SBLTT Groups	.05; 0	.008 sig
SECONDARY Change in Muscle Architecture-hypertrophy High Versus Low Frequency SBLTT Groups	.06; .05	.34

Summary

This study examines the effect of short burst interval treadmill training in ambulatory children with cerebral palsy. Half the sample will receive 20 sessions of training over 4 weeks, while half will receive the training over 10 weeks.

Eligibility Criteria

Inclusion Criteria

Ambulatory children with cerebral palsy Spasticity primary movement disorder Bilateral motor impairment (Diplegia) Gross Motor Function Classification System Levels II and III

Exclusion Criteria

undergone orthopedic or neurosurgery less than 12 months prior injection therapies (phenol, botulinum toxin) less than 3 months prior

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03373890). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.